Hot Stocks

Hot stocks are not about hype. They emerge when powerful themes, policy shifts, and capital flows converge. InvestorPlace analysts track fast-moving market narratives, especially in technology, AI, and infrastructure, to identify stocks drawing outsized attention and explain what is really driving those moves.

A Stock Flying High on Apple’s Tailwinds

Apple will be fine, but other related stocks may have more upside potential -- like the company behind the iPhone activation curtain, for example. Take a peek.

Netflix Stock May Never Shake Qwikster Calamity

Gone are the days of trading near $300. Netflix stock opened below $75 thanks to big subscriber losses and more disappointing news. Can it win its customers back?

Should You Buy the Dow — Procter & Gamble

Procter & Gamble is a venerable brand with wide reach, but PG stock doesn't have much growth value, and its dividend is lacking.

Netflix Stock in Double Digits — Monday’s IP Market Recap

Netflix (NFLX) stock pounded after the bell after Reed Hastings warns of plummeting DVD rental subscriptions, costly international expansion.

Cigna Deal Signals More Insurance Buyouts to Come

Smaller insurers are catching attention in the wake of expected consolidation.

Gold, Silver Track Stocks Higher on Earnings, Euro Zone Optimism

Gold was trading around $1,660 and silver $31.90 during Monday morning trading. Silver miners, including Coeur D'Alene and Pan American Silver, were soaring.

Icahn Cozies Up to WebMD

The billionaire investor takes a stake, but he may not need to get aggressive.

The No-Name Private Company Sticking It to Green Mountain

A no-name, privately-held company has developed a substantially cheaper single-cup pod -- compatible with Keurig brewers -- that will threaten Green Mountain's booming K-Cup business.

McDonald’s Cult Hit McRib Getting Mainstream Treatment

Instead of its traditional sporadic release, McDonald's will sell its popular pork sandwich -- the McRib -- at all U.S. stores through Nov. 14.

Should You Buy the Dow — Pfizer

Pfizer's financials are decent, as is its lineup of drugs and personal care products, but the stock is fully valued.

4 Stocks Getting Rejected Because of the NBA Lockout

With the first two weeks of the NBA season already canceled and the rest in limbo, companies that rely on the sport -- like Nike -- are going to come up short.

Amgen Leads Firms In Pancreatic Cancer Drug Chase

Amgen (Nasdaq:AMGN) is among several pharmaceutical companies working on a treatment for pancreatic cancer, the deadly disease that recently felled both Steve Jobs of Apple…

Gold, Silver Up in Advance of Weekend EU Debt Meeting

Gold prices headed higher Friday, trading around $1,640 in the morning, while silver also was up around $31.20.

Sporting Goods Stock Smackdown — Dick’s Vs. Hibbett

Dick's is making several business changes that should boost its bottom line, but Hibbett's focus on IT to control costs makes it an appealing buy, too.

Should You Buy the Dow — Microsoft

A dominant brand name, oodles of cash and a dividend. Microsoft isn't just a tech powerhouse -- it's a stock powerhouse.

Earnings Baggage Doesn’t Dog Airlines — Thursday’s IP Market Recap

Airline stocks soar despite Southwest earnings miss Thursday and AMR Corp.'s flub the day before.

Apple Stock Is the New Microsoft – Good, But Not Good Enough

Microsoft put out solid numbers Thursday, but -- like Apple just days before -- it wasn't enough for analysts, and the company's stock was punished as a result.

Gold, Silver Slightly Down Amid Positive U.S. News, European Struggles

Gold was trading in the low $1,620s Thursday morning, while silver was around $31.20. NovaGold Resources once again was bucking gold miners' decline.

Apple’s Speed Bump Doesn’t Derail Growth Story

Twelve months from now, Apple's "miss" will be long forgotten.